On ECHEMI
Home > Drugs > Coenzyme Q10 soft capsules

Coenzyme Q10 soft capsules

Function and Efficacy

1. Improvement of the utilization rate of ischemic myocardium. This product can improve the decrease in contractility and shortened duration of active potential caused by oxygen perfusion (Tyrode perfusion method) of woodchuck ventricular muscle. 2. Activation of myocardial mitochondrial ATP synthesis. According to the experiments on dogs, this product can improve the respiratory regulation rate (RCI) of myocardial mitochondria and the low ATP synthesis rate under ischemic conditions. In addition, in the perfusion experiments of rabbits and rats, this agent can not only resist the decrease in ATP synthesis accompanied by ischemia and reperfusion, but also promote ATP synthesis. 3. Improvement of low cardiac function Experiments on rats show that this product can inhibit the decrease in myocardial contractility caused by ischemia and reperfusion, and improve low myocardial function. 4. Myocardial protection This product has antioxidant and cell membrane stabilizing effects, which can be proved from the rat experiment that this agent can resist the cardiac disorders caused by doxorubicin hydrochloride, and in the ischemic experiment of dogs, it is proved that this product can inhibit the release of myocardial enzymes into the blood. 5. Anti-aldosterone effect In the experiment on rats, this agent can not only inhibit the secretion of aldosterone, but also antagonize the Na retention caused by aldosterone, promote the diuretic effect of Na, but does not affect the excretion of K.

Ingredients

The main ingredient of this product is coenzyme Q10, whose chemical name is 2,3-dimethoxy-5-methyl-6-{poly-[2-methylbutene(2)yl}-benzoquinone.

Name Description Content CAS NO. Manufacturer
Coenzyme Q10Ingredients

1. Improve the utilization rate of ischemic myocardium. 2. Activate the synthesis of ATP in myocardial mitochondria. 3. Improve the cardiac dysfunction caused by ischemia-reperfusion. 4. Protect the myocardium, including anti-oxidation and cell membrane stabilization. 5. Anti-aldosterone effect, inhibit aldosterone secretion and antagonize the Na retention caused by aldosterone, promote the diuretic effect of Na without affecting K excretion.

More
303-98-0 14

Appearance

This product is a soft capsule, and the contents are orange-yellow oily liquid.

Indication

Used as an auxiliary treatment for acute and chronic hepatitis, mild to moderate congestive heart failure and cancer.

Usage and Dosage

Oral administration: Adults take 1 tablet each time, 3 times a day, after meals.

Adverse Reactions

After taking this product, skin rash, stomach discomfort, loss of appetite, nausea, diarrhea, etc. may occasionally occur.

Precautions

It is contraindicated for those who are allergic to this product.

Special Population Medication

Precautions for children: Orally for children under 3 years old, 1/3 to 1/2 tablet at a time, 3 times a day; Orally for children over 3 years old, 1 tablet at a time, 3 times a day, after meals. Or as directed by a doctor. Precautions for pregnancy and lactation: Use with caution for pregnant and lactating women. Precautions for the elderly: Orally, 1 tablet at a time, 3 times a day, after meals, or as directed by a doctor.

Drug Interactions

Not yet clear

Storage

Protect from light, seal tightly, and store in a cool and dry place.

Packaging Specification

10mg

Validity Period

12 months

Manufacturer

Zhejiang Kanglaite Pharmaceutical Co., Ltd.

  • Founded in:

    1995-10-24
  • Address:

    No. 11 Road, Xiasha Economic and Technological Development Zone, Hangzhou, Zhejiang Province
  • Tax NO.:

    913301012539116620
  • Registered Funds:

    52.83 million yuan
  • Website:

  • Email:

Feedback & Suggestions
Send Message

Thank you for your feedback. If you require further assistance, please contact us by email at info@echemi.com or call us at +86-532-55729510.